Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Marketsglp-1insurancecoverageobesity

GLP-1 use falls sharply in 2026 as insurers drop coverage

Report ties the decline in prescriptions to payers pulling back on obesity drug benefits.

TR
By Tom Reyes · Markets Editor
Sep 17 14:06 ETSource: WGBH

The wire

  1. 01WGBH reports a sharp drop in GLP-1 usage in 2026 as insurers cut coverage.
  2. 02Coverage retrenchment could reverse recent access gains and hit manufacturer volumes.
  3. 03Extent of coverage losses by payer and region is unclear.

From the source

Sharp decline in GLP-1 usage in 2026 as insurance companies drop coverage

Read at news.google.com
Source URL https://news.google.com/rss/articles/CBMiuAFBVV95cUxQOFA4a3RLcHYxVm5FTUVhcVBQemozTHBNXy1WbzVZaEtuVmhzQ05nSlk5YWJxZndRVk9yUlMtV2VxQ3F4WGRhWmdBeVkzTUZFWE02QWRyNldUQW9VZkNKa0Z6c0N3dGZZSldzYzM4bDRMT191Ri1KOXQwMTJuMXc0YllPaFhObEg1U1F5bnk2VlhhVXdhR3BjRGlSQ1VVbXJTemdoamFsdlp4MUE0UGNOWWw2Mk1XSDY0?oc=5